- In August 2026, Coforge Limited announced it had expanded its long-running partnership with Pegasystems, gaining rights to build, brand, and commercially deliver integrated enterprise AI solutions powered by Pega’s decisioning and workflow automation platform.
- This deeper collaboration effectively turns Coforge into a scaled distribution and delivery channel for Pega technology, potentially simplifying adoption for global enterprises seeking AI-led transformation programs.
- Next, we’ll examine how Coforge’s expanded ability to package and deliver Pega-powered offerings could influence Pegasystems’ AI-focused investment narrative.
This technology could replace computers: discover 25 stocks that are working to make quantum computing a reality.
Pegasystems Investment Narrative Recap
To own Pegasystems, you need to believe its AI decisioning and workflow platform can stay essential as enterprises modernize complex operations. The expanded Coforge partnership looks incrementally positive for the near term AI adoption catalyst, but it does not remove key risks around revenue volatility from licenses, macro uncertainty in Europe, and the challenge of clearly differentiating Pega’s AI in a crowded market.
Among recent developments, the July 2026 launch of Pega Infinity 26 with an expanded AI suite matters most here. Infinity 26 is designed to make AI architecture more predictable and deployments more cost transparent, which aligns closely with Coforge’s new rights to package and deliver Pega-powered offerings. Together, they could reinforce the AI Blueprint and agentic workflow story that underpins current expectations for Pega Cloud growth and recurring revenue stability.
Yet behind the AI adoption story, one risk investors should be aware of is how easily large enterprises could still opt for integrated cloud suites from bigger rivals…
Read the full narrative on Pegasystems (it’s free!)
Pegasystems’ narrative projects $2.2 billion revenue and $345.7 million earnings by 2029. This requires 8.5% yearly revenue growth and about a $21.7 million earnings increase from $324.0 million today.
Uncover how Pegasystems’ forecasts yield a $43.00 fair value, a 15% upside to its current price.
Exploring Other Perspectives
Before this Coforge news, the most optimistic analysts were already assuming revenue could reach about US$2.5 billion and earnings about US$396.9 million by 2029, so you should recognize how their view of partner driven growth and competitive risks could shift sharply from here.
Explore 8 other fair value estimates on Pegasystems – why the stock might be worth 33% less than the current price!
Reach Your Own Conclusion
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
- A great starting point for your Pegasystems research is our analysis highlighting 3 key rewards that could impact your investment decision.
- Our free Pegasystems research report provides a comprehensive fundamental analysis summarized in a single visual – the Snowflake – making it easy to evaluate Pegasystems’ overall financial health at a glance.
Looking For Alternative Opportunities?
Opportunities like this don’t last. These are today’s most promising picks. Check them out now:
- AI is about to change healthcare. These 37 stocks are working on everything from early diagnostics to drug discovery. The best part – they are all under $10b in market cap – there’s still time to get in early.
- We’ve uncovered the 11 dividend fortresses yielding 5%+ that don’t just survive market storms, but thrive in them.
- Uncover the next big thing with 22 elite penny stocks that balance risk and reward.
This article by Simply Wall St is general in nature. We provide commentary based on historical data
and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your
financial situation. We aim to bring you long-term focused analysis driven by fundamental data.
Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.
Simply Wall St has no position in any stocks mentioned.
New:Manage All Your Stock Portfolios in One Place
We’ve created the ultimate portfolio companion for stock investors, and it’s free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks
Have feedback on this article? Concerned about the content? Get in touch with us directly.Alternatively, email editorial-team@simplywallst.com
You can copy Bill Ackman and buy Netflix. Knowing why you did is the hard part.
Netflix case is interesting. The scariest competitor is the one that does not need to make money. Amazon can run video at a loss forever because it is really a Prime retention tool with a content budget attached. On the other hand there is Youtube.
Pershing Square hasn’t beaten the S&P over the last five years, though the long-run record is genuinely good. I like Ackman as a person. I enjoy listening to Ackman and that’s about where it ends for me.
Mitchell Lawler
Market Insights
What 13F filings won’t tell you about a billionaire’s stock picks
Fresh 13F filings are where some investors go to find their next stock pick. The problem is it’s missing some of the most important details for making a good investment.
10
Sep 4, 2026
About NasdaqGS:PEGA
Pegasystems
Develops, markets, licenses, hosts, and supports enterprise software in the United States, rest of the Americas, the United Kingdom, rest of Europe, the Middle East, Africa, and the Asia-Pacific.
Flawless balance sheet and undervalued.
Similar Companies
Market Insights
What 13F filings won’t tell you about a billionaire’s stock picksMI
Mitchell Lawler
Great earnings season, but are the earnings real?AN
Andrew Legget
Which payment stocks actually get paid?MI
Mitchell Lawler
Advertisement
Weekly Picks
Lou_Baseneseon Oncolytics Biotech·18 days ago
The Team Behind a $2 Billion Johnson & Johnson (JNJ) Deal Just Took Over This $105 Million Cancer Biotech
Fair Value:US$3.575.9% undervalued
65followersusers have followed this narrative
·1commentusers have commented on this narrative
·17likesusers have liked this narrative
AN
andrei9868on ServiceNow·21 days ago
The Platform Turning Enterprise Chaos into Autonomous Workflows
John_Ericon Vistra·5 days ago
Vistra Fell 38%. Adjusted EBITDA Rose 31%. Here’s the $472 Million Reason They Disagree.
HarishPKon EverQuote·15 days ago
EverQuote and an Asymmetric Investment Opportunity
RecentlyUpdated Narratives
TimLeeon Gold Li Holdings Berhad·about 1 hour ago
Gold Li IPO: Johor Property Developer Builds Its Next Growth Chapter
Fair Value:RM 0.2363.0% undervalued
1followerusers have followed this narrative
·0commentsusers have commented on this narrative
·0likesusers have liked this narrative
QU
QuanDon Shopify·about 6 hours ago
The Default Platform for Entrepreneurs that Keeps Compounding
John_Ericon Hamilton Lane·about 10 hours ago
Analysts Cut Their Targets. The Co-Chairman Cut a Check.
Popular Narratives
oscargarciaon NVIDIA·3 months ago
The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.
John_Ericon MercadoLibre·about 13 hours ago
MercadoLibre and the Spreadsheet Trick That Decides Everything
CubanEroson Microsoft·2 months ago
A wonderful business at reasonable price.
Fair Value:US$419.9119.0% overvalued
224followersusers have followed this narrative
·0commentsusers have commented on this narrative
·9likesusers have liked this narrative
